Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 798 results for "tarrytown"

WestconGroup Enhances Cloud Portfolio With Addition of QTS Rea...

QTS REALTY TRUST, INC. (NYSE:QTS) Intraday Stock Chart Today : Thursday 19 March 2015 TARRYTOWN, N.Y. , March 19, 2015 /PRNewswire/ -- WestconGroup, the leading value-added global distributor of security, unified communications, network ... ADVFN India, 1 week ago
[x]  

PsychoGenics Obtains a License to α-synuclein Transgenic Mouse Models of Parkinson´s disease

TARRYTOWN, N.Y.--(BUSINESS WIRE)-- PsychoGenics announced today that it has obtained a license from the University of California, San Diego School of Medicine to two of their α-synuclein transgenic mouse models, over-expressing human wild type ...
 CNBC1 week ago PsychoGenics Inc. Obtains A License To ?-Synuclein Transgenic Mouse Models Of Parkinson's Disease  BioSpace1 week ago
[x]  

Progenics reports 4Q loss

On a per-share basis, the Tarrytown, New York-based company said it had a loss of 18 cents. For the year, the company reported net income of $4.4 million, or 6 cents per share, swinging to a profit
 Yahoo! UK and Ireland2 weeks ago

Goody's®, PediaCare® and Little Remedies® Launch Interactive Consumer Loyalty Program

TARRYTOWN, N.Y.--( BUSINESS WIRE )--Prestige Brands, Inc., the parent company of Goody's® Powder, PediaCare® and Little Remedies®, has launched an innovative online rewards program for consumers of these healthcare brands. The ...
 Business Wire3 weeks ago Goody 's ®, PediaCare ® and Little Remedies ® Launch Interactive Consumer Loyalty Program  Stockwatch3 weeks ago
[x]  

Resilience and PsychoGenics Announce a Drug Discovery Partnership

Companies will Work Together to Identify New Treatments for PTSD BOSTON & TARRYTOWN, N.Y.--(BUSINESS WIRE)-- Resilience Therapeutics, Inc. (Resilience) and PGI Drug Discovery LLC (PsychoGenics), today announced that they have entered ...
 CNBC4 weeks ago
[x]  

The Photo That Made Me: Stephen Shore, Tarrytown, N.Y., 1960

TIME LightBox talks to Stephen Shore as part of our series The Photo That Made Me , in which photographers tell us about the one photograph they made that they believe jump-started their career, garnered them international attention, or simply ...
 Time1 month ago

EYLEA® (aflibercept) Injection Receives FDA Approval for the Treatment of Diabetic Retinopathy in Patients with Diabetic Macular Edema (DME)

Diabetic retinopathy in patients with DME is the fourth approved indication for EYLEA in the U.S. PR Newswire TARRYTOWN, N.Y., March 25, 2015 TARRYTOWN, N.Y. , March 25, 2015 /PRNewswire/ --Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) ...
 Reuters5 days ago EYLEA ® (aflibercept) Injection Receives FDA Approval for the Treatment of Diabetic Retinopathy in Patients with Diabetic Macular Edema (DME)  Stockwatch5 days ago EYLEA(R) (aflibercept) Injection Receives EU Approval for the Treatment of Visual Impairment Due to Macular Edema Secondary to Retinal Vein Occlusion  Healthcare Sales & Marketing Network1 month ago Regeneron (REGN)'s Eylea Beats Genentech (RHHBY) in Rare Face Off Over Some Vision Loss Cases 2/20/2015  ClinicSpace1 month ago
[x]  
PRWeb

Westchester Library System Presents Breakfast with Frank Bruni

Celebrating Westchester Libraries: Unlimited Possibilities! Tarrytown, NY (PRWEB) March 19, 2015 The Westchester Library System (WLS) will present Breakfast with Frank Bruni Celebrating Westchester Libraries: Unlimited Possibilities! on ...
 MySanAntonio1 week ago Progenics Pharmaceuticals Announces Fourth Quarter and Year-End 2014 Financial Results  Review Seeker2 weeks ago Progenics Pharmaceuticals, Inc. (PGNX) Presents Positive Phase 2 Data For PSMA ADC In Metastatic Castration-Resistant Prostate Cancer 2/26/2015  ClinicSpace1 month ago OmniMD Receives Surescripts 2014 White Coat of Quality Award  ThomasNet1 month ago
[x]  
EuroInvestor

Sanofi and Regeneron Announce 18-Month Results of ODYSSEY LONG TERM Trial with Praluent (alirocumab) Published in The New England Journal of Medicine

- Fewer major cardiovascular events observed with Praluent in post hoc analysis - PARIS and TARRYTOWN, N.Y. , March 15, 2015 /PRNewswire/ -- Sanofi and Regeneron Pharmaceuticals, Inc. today announced that 18-month (78-week) results of a Phase 3 ...
 Morningstar.com2 weeks ago Regeneron and Sanofi Announce 18-Month Results of ODYSSEY LONG TERM Trial with Praluent (alirocumab) Published in The New England Journal of Medicine  Benzinga.com2 weeks ago Sanofi and Regeneron to present new data from investigational agent Praluent (alirocumab) phase 3 program at ACC.15  Cardiovascular Business2 weeks ago Sanofi and Regeneron Release 18-Month Results of Odyssey Long Term Trial with Praluent (alirocumab) Published in The New England Journal of Medicine [Professional Services Close - Up]  Pharmacy Choice1 week ago
[x]  

Amgen, Regeneron Stocks Go Up as Drugs Bring Cholesterol Down

Shares of Thousand Oaks, Calif.-based Amgen rose 5.7 percent today, to close at $163.03, while Tarrytown, New York-based Regeneron climbed 5.2 percent to $451.77. Both companies are seeking FDA approval for their new medicines, which are both given ...
 Austin American Statesman2 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - tarrytown
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less